430 - SARS-CoV-2 in waste water

Uwagi dotyczące produktu

LGC now offers proficiency testing samples for the detection of SARS-CoV-2 (COVID-19) in wastewater by nucleic acid amplification testing. Samples are provided in a waste water matrix. They are non-infectious and are compatible with molecular assays that target CDC and WHO consensus gene sequence regions ORF1a, RdRp, E (Envelope), N (Nucleocapsid) and/or S (Spike). As increasing monitoring of environmental samples, using various methods, is carried out, it is essential that laboratories ensure that their application of methods and subsequent results are reliable and accurate using external quality assurance tools, including proficiency testing.

"Governments, health bodies, hospitals, virology labs and indeed most of the world’s population find themselves locked in a war with the novel virus COVID-19. LGC is directly involved in COVID-19 related work, from supporting diagnostic kit manufacturers, diagnostic testing and clinical research to providing quality assurance tools to ensure reliability of measurements being made. It is our hope that by using this new wastewater proficiency testing program for SARS-CoV-2, external quality assurance measures will be in place to support all such testing worldwide. Together we can ensure accurate and reliable testing as the world unites to combat the spread of the virus”
Brian Brookman, Chief Scientific Officer, LGC Proficiency Testing

Dane analitu